Coeptis Therapeutics Holdings, Inc. (COEP) Stock Overview
Explore Coeptis Therapeutics Holdings, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Coeptis Therapeutics Holdings, Inc. (COEP)
Key Financials
Key Financials
Market Cap
38.6M
P/E Ratio
-6.11
EPS (TTM)
$-2.81
ROE
-0.48%
COEP Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Coeptis Therapeutics Holdings, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of COEP on the NASDAQ shows an RSI of 22.74, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.
Key metrics behind Coeptis Therapeutics Holdings, Inc.'s NASDAQ-traded stock include a P/E ratio of -6.11 and a market capitalization of 38.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of COEP on the NASDAQ.